PLANTATION, Fla., Sept. 27, 2021 /CNW/ - Akumin Inc. (NASDAQ:
AKU) (TSX: AKU) ("Akumin") is providing this update on the status
of the management cease trade order granted by the Ontario
Securities Commission (the "OSC"), as principal regulator of
Akumin, on August 20, 2021 (the
"MCTO") under National Policy 12-203 – Management Cease Trader
Orders ("NP 12-203"). The MCTO was granted following Akumin's
application to the OSC once it was determined it was not in a
position to file its interim financial report for the quarter ended
June 30, 2021 along with the related
management's discussion and analysis and CEO and CFO certificates
(collectively, the "Required Reports") by the reporting deadline of
August 16, 2021, as initially
announced on August 15, 2021 (the
"Default Announcement"). The management cease trade order prevents
the officers and/or directors named in the order from trading in
Akumin's securities but does not affect the ability of other
shareholders, including the public, to trade in securities of
Akumin.
Akumin is continuing to work to complete the preparation of the
analysis to conclude and facilitate the review of the Required
Reports at the earliest possible date and currently expects to be
in a position to file the Required Reports within 60 days of the
original filing deadline, being October 15,
2021.
Akumin confirms that since the date of the Default Announcement:
(i) there has been no material change to the information set out in
the Default Announcement that has not been generally disclosed;
(ii) there has been no failure by Akumin in fulfilling its stated
intentions with respect to satisfying the provisions of the
alternative information guidelines set out in NP 12-203;
(iii) there has not been any other specified default by Akumin
under NP 12-203; and (iv) there is no other material
information concerning the affairs of Akumin that has not been
generally disclosed.
Akumin confirms that it will continue to satisfy the provisions
of the alternative information guidelines under NP 12-203 by
issuing bi-weekly default status reports in the form of news
releases for so long as it remains in default of the above-noted
filing requirements.
About Akumin Inc.
Akumin is a national partner of choice for U.S. hospitals,
health systems and physician groups, with comprehensive solutions
addressing outsourced radiology and oncology service line needs.
With the acquisition of Alliance HealthCare Services, Akumin now
provides (1) freestanding, fixed-site outpatient diagnostic imaging
services through a network of more than 170 owned and/or operated
independent imaging centers located in 11 states; and (2)
outpatient radiology and oncology solutions to more than 1,000
hospitals and health systems in 46 states. By combining clinical
and operational expertise with the latest advances in technology
and information systems, Akumin and its ~4,000 Team Members
facilitate more efficient and effective diagnosis and treatment for
patients and their providers in 46 states. Akumin's imaging
procedures include MRI, CT, positron emission tomography (PET and
PET/CT), ultrasound, diagnostic radiology (X-ray), mammography, and
other interventional procedures; our cancer care services include a
full suite of radiation therapy and related offerings. For more
information, visit www.akumin.com and
www.alliancehealthcareservices-us.com.
Forward Looking Information
Certain statements contained in this press release may
constitute forward-looking information. These statements relate to
future events or future performance. The use of any of the words
"could", "intend", "expect", "believe", "will", "projected",
"estimated", "proposed" and similar expressions and statements
relating to matters that are not historical facts are intended to
identify forward-looking information and are based on Akumin's
current belief or assumptions as to the outcome and timing of such
future events. In particular, this release contains forward-looking
information relating to the anticipated filing of the Required
Reports and Akumin's intentions to continue to satisfy the
provisions of the alternative information guidelines under NP
12-203. Such forward-looking information are subject to risks and
uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the
statements, including, but not limited to, the risks described in
greater detail in the "Risk Factors" section of Akumin's Annual
Information Form dated March 31,
2021, which is available at www.sedar.com and www.sec.gov.
These risks are not intended to represent a complete list of the
risks that could affect Akumin; however, these risks should be
considered carefully. Further, various assumptions or factors are
typically applied in drawing conclusions or making the forecasts or
projections set out in forward-looking information. Those
assumptions and factors are based on information currently
available to Akumin. The forward-looking information contained in
this release is made as of the date hereof and Akumin is not
obligated to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable securities laws. Because of the
risks, uncertainties and assumptions contained herein, investors
should not place undue reliance on forward-looking information. The
foregoing statements expressly qualify any forward-looking
information contained herein.
The TSX has not in any way passed upon the merits of and has
neither approved nor disapproved the contents of this news
release.
SOURCE Akumin Inc.